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Summary
 
Differentiation of human T cells into T helper (Th)1 and Th2 cells is vital for the development
of cell-mediated and humoral immunity, respectively. However, the precise mechanism re-
sponsible for the Th1 cell differentiation is not fully clarified. We have studied the expression
and function of Txk, a member of the Tec family of nonreceptor tyrosine kinases. We found
that Txk expression is restricted to Th1/Th0 cells with IFN-
 
g
 
 producing potential. Txk trans-
fection of Jurkat T cells resulted in a several-fold increase of IFN-
 
g
 
 mRNA expression and
protein production; interleukin (IL)-2 and IL-4 production were unaffected. Antisense oli-
godeoxynucleotide of Txk specifically inhibited IFN-
 
g
 
 production of normal peripheral blood
lymphocytes, antigen-specific Th1 clones, and Th0 clones; IL-2 and IL-4 production by the T
cells was unaffected. Txk cotransfection led to the enhanced luciferase activity of plasmid
(p)IFN-
 
g
 
 promoter/enhancer (pIFN-
 
g
 
[-538])-luciferase–transfected Jurkat cells upon mitogen
activation. Txk transfection did not affect IL-2 and IL-4 promoter activities. Thus, Txk specif-
ically upregulates IFN-
 
g
 
 gene transcription. In fact, Txk translocated from cytoplasm into nu-
clei upon activation and transfection with a mutant Txk expression plasmid that lacked a nu-
clear localization signal sequence did not enhance IFN-
 
g
 
 production by the cells, indicating
that nuclear localization of Txk is obligatory for the enhanced IFN-
 
g
 
 production. In addition,
IL-12 treatment of peripheral blood CD4
 
1
 
 T cells enhanced the Txk expression, whereas IL-4
treatment completely inhibited it. These results indicate that Txk expression is intimately asso-
ciated with development of Th1/Th0 cells
 
 
 
and is significantly involved in the IFN-
 
g
 
 production
by the cells through Th1 cell–specific positive transcriptional regulation of the IFN-
 
g
 
 gene.
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g
 
T
 
helper type 1 cells are characterized by their secretion
of IFN-
 
g
 
 and induce macrophage cytotoxicity, de-
layed-type hypersensitivity, and enhanced cellular immu-
nity (1–3). It has been suggested that cytokines and their
receptors, transcription factors, MHC determinants, Ag
peptides, and costimulatory signals are important for Th1
and Th2 cell differentiation (1–9). However, to date, the
precise mechanism responsible for the differentiation and
development of polarized Th1 responses has not been fully
clarified in humans.
The Tec family has emerged recently as a subfamily of
nonreceptor tyrosine kinases and consists of Tec, Btk, Itk/
Tsk/Emt, Bmx, and Txk/Rlk (10–25). Because many
members of this family have been shown to be activated in
response to growth and differentiation stimuli in hemato-
poietic tissues, they are presumed to function in vivo as im-
portant signaling mediators (17); indeed, mutations in Btk
cause agammaglobulinemia in humans (18, 25).
Information concerning roles of Txk in human T lym-
phocyte function is limited. Txk displays highly cell type–
specific expression largely restricted to T cells and some
mast cell and myeloid cell lines (10, 11, 17). Txk has src
homology (SH)2
 
1
 
 and SH3 domains and a nuclear localiza-
tion signal sequence but lacks a pleckstrin homology do-
main (10–12, 17). The NH
 
2
 
 terminus of Txk in humans
and that of Rlk, a mouse homologue of human Txk, pos-
sess an unusual cysteine-rich string, suggesting that Txk/Rlk
functions in a manner that differs from the other pleckstrin
 
1
 
Abbreviations used in this paper:
 
 CAT, chloramphenicol acetyl transferase;
ODN, oligodeoxynucleotide; p, plasmid; RSV, Rous sarcoma virus; RT,
reverse transcription; SH, src homology. 
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homology domain–containing Tec family kinases (10–12,
17). More recently, Schneider et al. reported that Rlk is ca-
pable of phosphorylating CTL-associated antigen (CTLA)-4,
suggesting that Rlk may participate in CTLA-4 function (15).
The finding that mouse Rlk is expressed on Th1 but not
Th2 cells (10) prompted us to study the role of Txk in Th1
responses in humans. In this study, we found that Txk ex-
pression is restricted to Th1/Th0 cells and that Txk is in-
volved in the regulation of Th1 cytokine production by
human T lymphocytes.
 
Materials and Methods
 
Establishment of Ag-specific T Cell Clones and Cytokine Produc-
tion.
 
House dust mite–specific, Japanese cedar pollen 
 
Cryptome-
ria japonica
 
 1–specific, and purified protein derivatives of tubercu-
losis (PPD)-specific T cell clones were established by a standard
procedure using limiting dilution technique (26). All of the
clones expressed TCR-
 
a/b
 
, CD3, CD4, and CD45RO but were
negative for CD8. To induce cytokine production, the clones
were stimulated with the relevant Ag plus irradiated autologous
PBMCs and, in some experiments, irradiated autologous purified
monocytes as APCs for 18–24 h. IL-2 (BioSource International),
IL-4 (R & D Systems, Inc.), and IFN-
 
g
 
 (BioSource Interna-
tional) levels of culture supernatants were measured using ELISA
kits. We assigned Th0, Th1, and Th2 as follows (26): Th1 clones
that produce IFN-
 
g
 
 and undetectable IL-4 (
 
,
 
10 pg/ml); Th2
clones that produce IL-4 and undetectable IFN-
 
g
 
 (
 
,
 
10 pg/ml);
and Th0 clones that produce both IL-4 and IFN-
 
g
 
.
 
Purification of CD3
 
1
 
, CD4
 
1
 
CD3
 
1
 
, and CD8
 
1
 
CD3
 
1
 
 T Cells.
 
PBMCs were separated into sheep red blood cell (SRBC)-roset-
ted cells and unrosetted cells. CD3
 
1
 
 T cells were purified from
SRBC-rosetted cells by magnetic bead depletion (MBD) of
CD11a, CD14, CD19, and CD56 cells (27). CD4
 
1
 
CD3
 
1
 
 and
CD8
 
1
 
CD3
 
1
 
 T cell subsets were similarly purified by the MBD
technique. The resulting cell populations were always 
 
.
 
97%
pure for cells of the relevant phenotype.
 
Construction of Wild-Type and Mutant Txk Expression Vectors.
 
Human Txk cDNA in 
 
l
 
 phage was provided by Dr. G.W. Litman
(University of South Florida,
 
 
 
St. Petersburg, FL) (11). Full length
Txk cDNA was amplified by PCR using a sense primer (CG-
GAATTCATGATCCTTTCCTCCTATAACA) and an anti-
sense primer (TTCTCTAGATCACCAGGTTTCCGCAAT-
CTC), and the product was ligated into a mammalian expression
vector, pME18S (SR-
 
a
 
 promoter; provided by Dr. K.
Maruyama, Tokyo Medical and Dental University, Tokyo, Ja-
pan) (28). The vector pME18S-Txk carries the full length wild-
type human Txk cDNA.
The Txk mutant was created using the QuickChange site-
directed mutagenesis kit (Stratagene Inc.). In brief, pME18S-Txk
was used as a template. The primers containing the desired muta-
tion were employed for PCR amplification using PfuTurbo
DNA polymerase (Stratagene Inc.). The amplification cycle con-
sisted of 1 cycle of denaturation (95
 
8
 
C) for 1 min, followed by 18
cycles of denaturation (95
 
8
 
C) for 30 s, annealing for 1 min
(55
 
8
 
C), and polymerization for 10 min (68
 
8
 
C). After PCR cy-
cling, the PCR product was treated with DpnI, which is specific
for methylated and hemimethylated DNA, and the synthesized
nonmethylated DNA containing the desired mutation was recov-
ered. The resultant mutant vector was used for transformation of
 
Escherichia coli 
 
DH5
 
a
 
.
A part of the hypothetical nuclear localization sequence of
 
Txk, KRKP, was deleted from the wild-type Txk, and the rest of
Txk cDNA was kept intact (16, 17, 29). The primers used for
constructing the deletion mutant were as follows: KRKP-dele-
tion, 5
 
9
 
-CGGGCCGTGTGCAGCCGTCACTGCCTCCCC-
TCCCACCCTC-3
 
9
 
 and 5
 
9
 
-GAGGGTGGGAGGGGAGGC-
AGTGACGGCTGCACACGGCCCG-3
 
9
 
. Fidelity of all the
constructs was confirmed by DNA sequencing.
 
Transfection into Cell Lines and Luciferase Assay.
 
Purified plas-
mids were transfected into Jurkat and Raji cells by electropora-
tion as described (28). After a 48-h incubation, cells were col-
lected, counted, and stimulated with PHA (1 
 
m
 
g/ml) plus PMA
(10 ng/ml) or PMA (10 ng/ml) plus ionomycin (1 
 
m
 
g/ml) for 24 h
to induce lymphokine production. 5 
 
m
 
g of plasmid (p)IFN-
 
g
 
(-538)-luciferase (provided by Dr. C.B. Wilson, University of
Washington, Seattle, WA), 5 
 
m
 
g pRSV (Rous sarcoma virus)–
chloramphenicol acetyl transferase (CAT), and 10 
 
m
 
g of
pME18S-Txk (Txk transfection) or pME18S (empty vector;
mock transfection) was cotransfected into Jurkat cells.
pIL-2(-568)-luciferase (provided by Dr. C.B. Wilson) with
pRSV-CAT and pIL-4(-265)-CAT (provided by Dr. S.N. Geo-
ras, Johns Hopkins University, Baltimore, MD) with pGL-3 con-
trol vector (SV-40 promoter; Promega Corp.) were similarly
transfected. 48 h after transfection, the Jurkat cells were stimu-
lated with PHA plus PMA for 8 h. Thereafter, luciferase assay
and CAT-ELISA (Roche Diagnostics) of the cells were carried
out (30).
 
Antibodies.
 
Txk expression of transfected cells and normal
lymphocytes was studied by immunoblotting (28), immunocy-
tochemical staining (31), and immunofluorescence analysis using
goat anti–Txk Ab (Santa Cruz Biotechnology). Fluorescence-
conjugated anti–IFN-
 
g
 
 mAb (Immunotech) was used for intracy-
toplasmic IFN-
 
g
 
 staining.
 
Immunofluorescence Staining of Intracytoplasmic Proteins.
 
Immu-
nofluorescence staining of intracytoplasmic proteins was carried
out by a modification of the method of Sander et al. (32). In
brief, the cells were fixed by using 4% paraformaldehyde and per-
meabilized by 0.1% saponin (Sigma Chemical Co.) in PBS with
0.01 M Hepes buffer solution. Thereafter, intracytoplasmic anti-
gens were stained with purified first Abs, biotin-conjugated sec-
ond Abs, and streptavidin–fluorochrome. Thereafter, the cells
were analyzed by flow cytometry. Appropriate control Abs were
included to define the background immunofluorescence of the
cells in this study.
 
Immunocytochemical Staining.
 
T cells or T cell clones were re-
covered and cytospin preparations of them were made. The sam-
ples were fixed with cold acetone for 15 min and were blocked
with 2% skim milk for 30 min. The samples were incubated with
first Abs overnight at 4
 
8
 
C. All subsequent procedures were per-
formed using an LSAB kit (DAKO JAPAN).
 
Reverse Transcription–PCR Analysis.
 
IFN-
 
g
 
 mRNA expres-
sion of Jurkat cells was estimated by reverse transcription (RT)-
PCR using limiting dilutions of cDNA to accurately estimate the
relative amounts of mRNA expression in different samples as
previously reported (31). Txk-transfected and mock-transfected
Jurkat cells were cultured for 48 h and then stimulated with PHA
plus
 
 
 
PMA for 8 h. Total RNA was extracted from these cells, and
was cDNA synthesized. The sequences of IFN-
 
g
 
, IL-4, and 
 
b
 
-actin
primers and PCR conditions were reported previously (33). For
amplification of Txk cDNA, the following primers were used:
Txk sense, TTGCTGTTCAGTGCAGAA; Txk antisense, GCA-
CCTTCTTTAGACTCT; 475-bp product.
 
Antisense Oligodeoxynucleotide and Cell Culture.
 
Sense (GGG-
CTACCATGAGGTTTC) and antisense (GAAACCTCATGG- 
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TAGCCC) oligodeoxynucleotides (ODNs) specific for Txk
were synthesized as a sulfonylated form. Peripheral blood T cells
and Ag-specific cloned T cells (10
 
6
 
 cells/ml) were incubated in
the presence of various concentrations of ODNs for several
hours. Thereafter, peripheral blood T cells were stimulated with
PHA (1 
 
m
 
g/ml) and Ag-specific cloned T cells with irradiated
autologous PBMCs plus the optimal concentration of Ag (26).
 
Results and Discussion
 
We first studied Txk expression of various cell types. Jur-
kat and MOLT-4 cells (T cell lines) but not Raji (a B cell
line)- nor EBV-transformed B cells expressed Txk. Both
peripheral blood CD4
 
1
 
 and CD8
 
1
 
 T cells expressed Txk;
peripheral blood B cells and monocytes, however, never
expressed it. We next asked whether Txk expression is re-
stricted to a certain T cell subpopulation, such as Th1 cells.
Various Ag-specific T cell clones that had been cultured for
7 d after the last stimulation with irradiated autologous PB-
MCs plus the relevant Ags were recovered. RT-PCR anal-
ysis revealed that all 20 Th1 cell clones and all 20 Th0
clones tested expressed Txk mRNA, whereas none of the
20 Th2 clones expressed it (Fig. 1 a).
Immunocytochemical staining confirmed that all Th1
and Th0 clones with various Ag specificities from several
donors expressed Txk; all of these clones have IFN-
 
g
 
 pro-
ducing potential (Fig. 1, a and b). However, Th2 clones,
regardless of Ag specificity or the donor, did not express
Txk at all (Fig. 1, a and b). Thus, there is an intimate asso-
ciation between Txk expression and Th1/Th0 clones with
IFN-
 
g
 
 producing potential.
We next studied the effects of Txk overexpression on
cytokine production by T cells. To this end, Jurkat cells
were transfected with pME18S-Txk. We used Jurkat cells
in these experiments because they produce relatively low
levels of Th1 cytokines upon mitogen activation. Overex-
pression of Txk by the transfection was confirmed by im-
munoblotting with anti-Txk Ab (Fig. 2 a). In parallel ex-
periments, Jurkat cells were stimulated with PHA plus
PMA. When we used ELISA to detect cytokine secretion,
Txk transfection resulted in several-fold more IFN-
 
g
 
 pro-
duction as compared with the mock transfection (Fig. 2 b).
We also confirmed that Txk transfection of Jurkat cells en-
hances IFN-
 
g
 
 production by using an IFN-
 
g
 
–specific
ELISpot assay (data not shown).
Similarly, intracytoplasmic IFN-
 
g
 
 staining of the Jurkat
cells was carried out. As shown in Fig. 2 c, Txk transfection
of Jurkat cells led to a several-fold increase of intracytoplas-
mic IFN-
 
g
 
–positive cells; in mock-transfected Jurkat cells
stimulated with PHA plus PMA, 13% were intracytoplas-
mic IFN-
 
g
 
–positive cells; in Txk-transfected Jurkat cells
stimulated with PHA plus PMA, 36% were intracytoplas-
Figure 1. Analysis of Txk expression of
human Ag-specific T cell clones. (a) RT-
PCR analysis of Txk expression of human
Th1, Th2, and Th0 cell clones. Unstimu-
lated T cell clones were used for analysis
of Txk mRNA expression. T cell clones
were stimulated for 12 h with the relevant
Ag plus irradiated monocytes as APCs and
analyzed for cytokine mRNA expression.
Results of five Th1, five Th0, and five
Th2 representative clones of various anti-
gen specificities from several different do-
nors are shown. (b) Representative Th1,
Th2, and Th0 cell clones were stained by
the immunocytochemical method for Txk
protein expression (magnification 250).
We studied a total of 20 Th1, 20 Th0,
and 20 Th2 clones with various Ag speci-
ficities from several donors. All of the Th1
cell clones were strongly positive for Txk
expression, whereas none of Th2 clones
expressed it. All of the Th0 clones were
positive for Txk expression with various
staining intensities. 
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mic IFN-
 
g
 
–positive cells (Fig. 2 c). Txk transfection did
not affect IL-2 production of the Jurkat cells (Fig. 2 b).
Txk-transfected and mock-transfected Jurkat cells did not
produce detectable levels of IL-4 upon stimulation (Fig. 2
b). Txk transfection of Raji cells did not induce IFN-
 
g
 
,
IL-2, or IL-4 production, even upon stimulation with
PMA plus ionomycin (Fig. 2 b). These results suggest that
Txk has a key role in IFN-
 
g
 
 production by T cells.
We next studied the IFN-
 
g
 
 mRNA expression of the
Jurkat cells. Txk transfection led to enhanced IFN-
 
g
 
mRNA expression by the Jurkat cells as compared with the
mock transfection (Fig. 2 d). We also examined whether
Txk transfection positively affects IFN-
 
g
 
 gene transcription
by enhancing IFN-
 
g
 
 promoter/enhancer activity. To
this end, we cotransfected pIFN-
 
g
 
(-538)-luciferase and
pME18S-Txk into Jurkat cells. We found that Txk trans-
fection induced several-fold more luciferase activity in
the  cells than the mock (pIFN-
 
g
 
[-538]-luciferase and
pME18S)-transfected cells (Fig. 2 e). As control cytokine-
promoter plasmids, we used pIL-2(-568)-luciferase and
pIL-4(-265)-CAT. We found that Txk transfection did not
affect activities of pIL-2 promoter-luciferase– and pIL-4
Figure 2. Effects of Txk transfection on IFN-g production by Jurkat cells. (a) Jurkat cells were transfected with pME18S (mock) and pME18S-Txk
(Txk). 48 h after transfection, the Jurkat cells were analyzed for Txk expression (molecular mass, 64 kD) by the immunoblotting method (28). (b) 48 h af-
ter transfection, Jurkat and Raji cells were stimulated with PHA plus PMA and PMA plus ionomycin, respectively. Cytokine production was measured
by ELISAs. IL-4 production was not detected in any of the transfected Jurkat cell cultures. Mean of triplicate cultures is shown. SEM never exceeded
10% of the mean and was thus omitted. Without mitogenic stimulation, neither Jurkat nor Raji cells produced the cytokines tested, so the results were
omitted. Results shown are representative of six independent experiments. ND, not detected. (c) Intracytoplasmic IFN-g protein expression was assessed
by immunofluorescence analysis with anti–IFN-g mAb of the Jurkat cells. Txk- and mock-transfected Jurkat cells were cultured for 48 h to induce Txk
expression. The transfected cells were stimulated with PHA plus PMA for 8 h or kept unstimulated and then analyzed for intracytoplasmic IFN-g expres-
sion. (d) Limiting dilution RT-PCR analysis of IFN-g mRNA expression. The transfected Jurkat T cells were stimulated with PHA plus PMA for 6 h.
We used limiting dilution RT-PCR technique, where varying dilutions of cDNAs were subjected to PCR amplification to more precisely determine ef-
fects of Txk transfection on IFN-g mRNA expression. Lanes 1, 2, and 3 represent 10, 5, and 2% of the total cDNA used for PCR amplification, respec-
tively. Other PCR reaction conditions were exactly the same for lanes 1, 2, and 3. This was to show that PCR reaction ranges within the logarithmic
phase of the PCR amplification. (e) Luciferase assay of the Jurkat cells. Jurkat cells were cotransfected with pIFN-g(-538)-luciferase, pRSV-CAT, and
pME18S-Txk or pME18S. 48 h after transfection, half of the cells were stimulated with PHA plus PMA for 8 h, and the remaining cells were kept un-
stimulated. pRSV-CAT (for pIFN-g promoter-luciferase and pIL-2 promoter-luciferase) and pGL-3 control (for pIL-4 promoter-CAT) were used for
estimating the transfection efficiency. According to the transfection efficiency, the luciferase and CAT activities of the promoter assays were corrected. 
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promoter-CAT–transfected Jurkat cells, regardless of the
presence or absence of mitogenic stimulation. The results
revealed that Txk acts specifically on IFN-
 
g
 
 promoter/en-
hancer (-538) and upregulates IFN-
 
g
 
 gene transcription.
Because Txk has a hypothetical nuclear localization sig-
nal sequence (16, 17, 29), we examined nuclear transloca-
tion of the Txk protein in response to activation signals.
Jurkat cells were stimulated with either PHA or IL-12, and
subsequent localization of Txk was assessed by immunocy-
tochemical staining (Fig. 3 a). Unstimulated Jurkat cells
showed cytoplasmic localization of Txk. Txk protein accu-
mulated in the nuclei of Jurkat cells after treatment for 1 h
with PHA. The nuclear accumulation of Txk was specific
for PHA, because Txk protein remained in the cytoplasm
of Jurkat cells treated with IL-12. The results suggest that
Txk itself translocates into nuclei and enhances IFN-
 
g
 
 gene
transcription in T cells.
To study the role of nuclear translocation of the Txk
protein upon activation, we constructed a pME18S-mutant
Txk vector expressing Txk protein that lacked a nuclear lo-
calization signal sequence (KRKP-deleted) (16, 17, 29).
Jurkat cells were transfected with either wild-type or mu-
tant Txk expression vector and cultured for 48 h. In the
mutant Txk–transfected Jurkat cells, a vast majority of the
(mutant) Txk protein stayed in cytoplasm and did not
translocate into nuclei, even after stimulation with PHA
plus PMA. However, very small amounts of endogenous
Txk in the Jurkat cells translocated into nuclei upon activa-
tion. In contrast, in the wild-type Txk–transfected Jurkat
cells, Txk protein translocated into nuclei in response to
the stimulation (Fig. 3 b).
We measured IFN-
 
g
 
 production of the transfected Jur-
kat cells in parallel experiments. We found that wild-type
Txk did enhance IFN-
 
g
 
 production, whereas nuclear lo-
calization signal sequence (KRKP)-deleted Txk did not af-
fect IFN-
 
g
 
 production by the transfected Jurkat cells.
These results indicate that nuclear localization of Txk is
obligatory for its effect on cytokine expression (Fig. 3 c).
To confirm the involvement of Txk in IFN-g produc-
tion by human T cells, we tested inhibition of IFN-g pro-
Figure 3. Expression and localization of Txk
in human T cells. (a) Nuclear translocation of
Txk upon mitogenic stimulation. Peripheral
blood T cells were cultured with IL-12 (1 ng/
ml) or PHA (1 mg/ml) or kept unstimulated for
various periods of time. Thereafter, the T cells
were stained with anti-Txk Ab by the immu-
nocytochemical method. Nuclear translocation
of Txk was evident in T cells treated for 60 min
with PHA but not in T cells treated with IL-12
for 60 min nor T cells incubated for 60 min in
medium alone (unstimulated). Magnification of
the results was 250. (b) Immunocytochemical
staining of wild-type Txk- and nuclear localization sequence–deleted mutant Txk–transfected Jurkat cells. Jurkat cells were transfected with pME18S
(mock), pME18S-Txk (wild type Txk), or pME18S-mutant (KRKP-deleted) Txk expression vector and cultured for 48 h. Thereafter, the cells were ac-
tivated with PHA plus PMA for 1 h. Respective cytospin preparations were made and stained with anti-Txk Ab. Control Ab did not stain at all, so results
of the control staining were omitted. The mutant Txk did not translocate into nuclei even upon activation. The results shown (magnification 250) are
representative of four independent experiments with essentially the same results. (c) Effects of nuclear localization sequence–deleted mutant Txk transfec-
tion on IFN-g production. Jurkat cells were transfected with pME18S (mock), pME18S-Txk (wild type), or mutant (KRKP-deleted) Txk expression
vector and cultured for 48 h. Thereafter, the cells were activated with PHA plus PMA for 24 h. IFN-g production by the transfected Jurkat cells was as-
sessed by ELISA. The results shown are representative of four independent experiments with essentially the same results.1152 Txk Regulates Th1 Cytokine Production in Humans
duction by Txk antisense ODN. Peripheral blood T lym-
phocytes were cultured in the presence of sense or
antisense ODN corresponding to the original translation
start site of Txk (16) for several hours and were then stimu-
lated with PHA. Antisense ODN, but not sense ODN,
specifically inhibited cytoplasmic expression of Txk (Fig. 4
a); IFN-g production of T cells was specifically inhibited
by the antisense ODN (Fig. 4 b). IL-2 and IL-4 production
were not modulated by either the sense or antisense ODNs
(Fig. 4 b). To further confirm that Txk antisense ODN in-
hibits IFN-g production, Ag-specific T cell clones were
cultured with ODNs and then stimulated with Ag plus ir-
radiated autologous PBMCs. Again, IFN-g production by
the Ag-specific Th1 and Th0 clones (Fig. 4 c), but not IL-4
production by the Ag-specific Th0 (Fig. 4 c) and Th2
clones (data not shown) was inhibited by the Txk anti-
sense ODN.
We also studied whether Txk expression of human T
cells is under the influence of Th1 cytokines. Normal pe-
ripheral blood CD41 T cells were cultured with various
concentrations of Th1 and Th2 cytokines. Intracytoplasmic
Txk protein in T cells was subsequently assessed by flow
cytometric analysis with anti-Txk Ab (Fig. 5). IL-2 treat-
ment of the CD41 T cells did not affect Txk expression
levels. IL-4 markedly reduced Txk expression of the CD41
T cells (Fig. 5). In contrast, IL-12 treatment for 4 h was
sufficient to enhance Txk expression of the CD41 T cells
(Fig. 5). This further supports an intimate association be-
tween Th1 cells and Txk expression. IL-12 may be in-
volved in the polarization toward Th1 cells of T cells via
Txk but is not affected by the outcome of IFN-g produc-
tion via Txk.
It has been shown that Txk protein includes two iso-
forms that arise by alternative initiation of translation from
the same cDNA (16). We confirmed that Txk protein has
two isoforms in COS cells when overexpressed by transfec-
tion (data not shown). However, Jurkat cells and normal
PBLs almost exclusively express a longer isoform of Txk
Figure 4. Effects of Txk antisense ODN on cytokine production by human T cells. (a) Txk expression of normal peripheral blood T cells treated with
Txk antisense ODN was analyzed. Txk expression was specifically reduced when treated with Txk antisense ODN, but not sense ODN (both 10 mM),
for 12 h. The result shown (magnification 250) is representative of three independent experiments with essentially the same results. (b) Normal peripheral
blood T cells were cultured in the presence of Txk antisense ODN for 12 h to reduce Txk expression. Thereafter, the T cells were stimulated with PHA.
The result shown is representative of three independent experiments with essentially the same results. Mean of triplicate cultures is shown. SEM never
exceeded 10% of the mean and was thus omitted. (c) PPD- and Crj-1-specific T cell clones pretreated with the ODNs (5 mM, which inhibits Txk ex-
pression of the clones) were stimulated with the relevant Ag plus irradiated autologous PBMCs. The similar results were reproduced in the experiments
using cells from different donors and different Ag-specific T cell clones. Mean of triplicate cultures is shown. SEM never exceeded 10% of the mean and
was thus omitted.
Figure 5. Effects of cytokine
treatment on Txk expression. Puri-
fied peripheral blood CD41 T cells
were cultured with various con-
centrations of recombinant cyto-
kines for 4 h. Thereafter, intracy-
toplasmic Txk expression of the T
cells was analyzed by immunofluo-
rescence staining using anti-Txk
Ab. IL-12 (1 ng/ml) enhanced
whereas IL-4 (10 ng/ml) reduced Txk expression of the T cells. IL-2 (2
ng/ml) treatment did not significantly affect Txk expression. The results
shown are representative of five independent experiments with essentially
the same results.1153 Kashiwakura et al.
(Fig. 2 a). In normal PBLs, antisense ODN, which primes
with the original translation start site (the longer isoform),
almost completely abolished Txk staining (Fig. 4 a), sug-
gesting that a longer isoform of Txk mainly mediates regu-
lation of IFN-g production in T cells.
In summary, Txk expression is restricted to Th1/Th0
cells with IFN-g producing potential and is significantly in-
volved in IFN-g gene transcription and subsequent IFN-g
protein production in human T cells.
We believe that this is the first description of Txk involve-
ment in IFN-g production by human Th1 cells. More re-
cently, we have found that Txk is phosphorylated and trans-
locates into nuclei upon activation, and Txk or a protein
complex including Txk binds to the IFN-g promoter se-
quence (Nagafuchi, H., N. Suzuki, and T. Sakane, unpub-
lished observation). Thus, we are currently investigating
whether Txk itself or a protein complex including Txk acts as
a Th1 cell–specific transcription factor for the IFN-g gene.
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